(Natural News) Slowly but surely, the Biden regime is eliminating access to monoclonal antibody treatments in the United States. The latest reports show that another 14 states are now prohibited from receiving shipments of sotrovimab, which is manufactured by GlaxoSmithKline (GSK) and Vir Biotechnology. A March 30 announcement from the Department of Health and Human […]

(Natural News) New research out of the University of North Carolina (UNC) found that Merck’s new anti-covid drug molnupiravir causes cancer. The so-called “miracle” drug, which we reported is really just a rip-off of ivermectin, was applied to hamster cells over the course of 32 days. During this time, it was discovered that the drug […]

(Natural News) Pharmaceutical company Merck recently announced that the updated data on their experimental Wuhan coronavirus (COVID-19) pill suggest it is less effective than previously reported. The company will now move forward to test the treatment for safety. The pill molnupiravir showed only a 30 percent reduction in hospitalization and death based on data from […]

(Natural News) Don’t expect Big Pharma companies to stop developing new treatments for the Wuhan coronavirus (COVID-19). Not when they can turn a $17.74 manufacturing price into $712 selling price. Merck’s molnupiravir is the latest alleged answer to ending the pandemic and reports say it can cut hospitalizations and deaths of unvaccinated people infected with coronavirus by at […]

(Natural News) (Article by Matt Taibbi republished from Taibbi.Substack.com) Yesterday, I ran a story that had nothing to do with vaccines, about the seeming delay of the development of a drug called molnupiravir (see the above segment with the gracious hosts of The Hill: Rising for more). In the time it took to report and write that piece, conventional wisdom turned […]

(Natural News) According to a report by drug pricing experts at the Harvard School of Public Health (HSPH) and King’s College Hospital in London, a five-day course of molnupiravir only costs $17.74 to produce. So why is Merck charging the U.S. government $712, or over 40 times the production price of the drug? Is molnupiravir key to treating coronavirus? […]

(Natural News) A critical care doctor said the U.S. is wasting taxpayer’s money on its purchase of drug manufacturer Merck’s Wuhan coronavirus (COVID-19) antiviral treatment. Front Line COVID-19 Critical Care Alliance (FLCCC) President Dr. Pierre Kory warned that the Biden administration should not pay Merck for a COVID-19 drug “which has already failed in hospitalized patients.” […]